XLY Stock Overview
Operates as a consumer packaged goods company in the cannabis products market in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Auxly Cannabis Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.045 |
| 52 Week High | CA$0.07 |
| 52 Week Low | CA$0.01 |
| Beta | 1.27 |
| 11 Month Change | 28.57% |
| 3 Month Change | -10.00% |
| 1 Year Change | 125.00% |
| 33 Year Change | -83.93% |
| 5 Year Change | -95.11% |
| Change since IPO | -96.93% |
Recent News & Updates
Auxly Cannabis Group Inc.'s (TSE:XLY) Shares Leap 60% Yet They're Still Not Telling The Full Story
Aug 09
Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower
Jun 19Recent updates
Auxly Cannabis Group Inc.'s (TSE:XLY) Shares Leap 60% Yet They're Still Not Telling The Full Story
Aug 09Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower
Jun 19Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?
Apr 27A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb
Mar 21Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company
Feb 03Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper
Dec 19Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?
Oct 17Is Auxly Cannabis Group (TSE:XLY) Using Debt In A Risky Way?
Jul 14Auxly Cannabis Group Inc. (TSE:XLY) Could Be Riskier Than It Looks
Apr 17The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically
Aug 11Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?
Jul 21Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%
Aug 18Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates
Apr 29Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)
Mar 24A Look At Auxly Cannabis Group's (CVE:XLY) Share Price Returns
Jan 28
Shareholder Returns
| XLY | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -6.0% | 0.9% |
| 1Y | 125.0% | 37.6% | 15.8% |
Return vs Industry: XLY exceeded the Canadian Pharmaceuticals industry which returned 37.6% over the past year.
Return vs Market: XLY exceeded the Canadian Market which returned 15.8% over the past year.
Price Volatility
| XLY volatility | |
|---|---|
| XLY Average Weekly Movement | 19.5% |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in CA Market | 16.6% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: XLY's share price has been volatile over the past 3 months.
Volatility Over Time: XLY's weekly volatility has decreased from 39% to 19% over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 369 | Hugo Alves | www.auxly.com |
Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. It focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. The company offers cannabis products under various forms, including vape catridges, infused pre-rolls, pre-rolled, vape pens, milled and dried flower, concentrates, chocolates, soft chews, oil drops, capsules, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names.
Auxly Cannabis Group Inc. Fundamentals Summary
| XLY fundamental statistics | |
|---|---|
| Market cap | CA$56.39m |
| Earnings (TTM) | -CA$45.41m |
| Revenue (TTM) | CA$109.54m |
0.5x
P/S Ratio-1.2x
P/E RatioIs XLY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XLY income statement (TTM) | |
|---|---|
| Revenue | CA$109.54m |
| Cost of Revenue | CA$76.82m |
| Gross Profit | CA$32.72m |
| Other Expenses | CA$78.13m |
| Earnings | -CA$45.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.036 |
| Gross Margin | 29.87% |
| Net Profit Margin | -41.45% |
| Debt/Equity Ratio | 60.7% |
How did XLY perform over the long term?
See historical performance and comparison